Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:October 29, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:October 29, 2014Terminated
Condition(s):Prostate CancerLast Updated:April 29, 2015Completed
Condition(s):Prostate Adenocarcinoma; Recurrent Prostate CarcinomaLast Updated:November 14, 2023Active, not recruiting
Condition(s):Adenocarcinoma of the Prostate; Recurrent Prostate CancerLast Updated:January 7, 2013Terminated
Condition(s):Prostate CancerLast Updated:October 31, 2018Completed
Condition(s):Prostate CancerLast Updated:March 17, 2014Unknown status
Condition(s):Stage I Prostate Adenocarcinoma; Stage II Prostate Adenocarcinoma; Stage III Prostate AdenocarcinomaLast Updated:March 28, 2023Active, not recruiting
Condition(s):Prostate CancerLast Updated:July 16, 2013Completed
Condition(s):Prostate CancerLast Updated:January 18, 2023Completed
Condition(s):Prostate CancerLast Updated:November 29, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.